Are peptides legal in India?
Sourced guide to the legal status of peptides in India, refreshed automatically from live research.
Overall Status: Restricted
Short answer: Peptides such as BPC-157 and TB-500 are not approved drugs in India and cannot be lawfully manufactured, sold, or marketed for human use, while related peptides that are approved medicines (e.g., semaglutide/tirzepatide, human growth hormone/somatropin) are legal only as prescription-only drugs under India's Drugs and Cosmetics Act.
Important: This information is for educational purposes only and does not constitute legal advice. Laws and enforcement policies change. Consult a qualified attorney for specific legal guidance.
Overview
Peptides are not treated in India as a single unified legal category: unapproved research peptides like BPC-157 and TB-500 fall outside any approved drug list and cannot legally be sold as medicines or supplements, whereas peptide-class drugs that have gone through formal approval (semaglutide, tirzepatide, somatropin/HGH) are legal but restricted to prescription-only sale. The Central Drugs Standard Control Organisation (CDSCO), headed by the Drugs Controller General of India (DCGI), regulates all drugs including peptide biologics under the Drugs and Cosmetics Act, 1940 and the New Drugs and Clinical Trials Rules, 2019. Selling an unapproved 'new drug' (which includes most research peptides) without CDSCO approval is a criminal offence, and prescription-only peptide medicines require a registered medical practitioner's prescription to be dispensed by a licensed pharmacy.
Key Points
- India's Drugs and Cosmetics Act, 1940 and the New Drugs and Clinical Trials Rules, 2019 require any new pharmaceutical substance, including peptide compounds, to receive CDSCO/DCGI approval before it can be legally manufactured, imported, sold, or marketed in India. [1]
- CDSCO, functioning under the Ministry of Health and Family Welfare, is India's national drug regulator responsible for approving new drugs, biologics, and setting prescription requirements. [2]
- Peptide medicines that have completed India's formal approval process, such as semaglutide and tirzepatide for diabetes/weight management and somatropin (human growth hormone) for growth hormone deficiency, are legal in India only as prescription-only drugs dispensed against a registered doctor's prescription. (No reliable source found for this point -- flagged as unverified rather than stated as fact.)
- Research-grade or 'not for human consumption' peptides such as BPC-157 and TB-500 have no CDSCO marketing approval in India, so manufacturing or selling them as an injectable or ingestible product for human use would constitute selling an unapproved new drug, an offence under the Drugs and Cosmetics Act. [1]
- Indian law generally permits an individual to personally import a small, limited quantity of a legally prescribed medicine (commonly understood as up to about a three-month supply) for their own treatment when accompanied by a valid prescription, but this personal-import allowance applies to approved prescription drugs and does not legalize unapproved research peptides. (No reliable source found for this point -- flagged as unverified rather than stated as fact.)
- Selling, distributing, or manufacturing an unapproved drug in India can trigger criminal penalties under the Drugs and Cosmetics Act, including imprisonment and fines, in addition to product seizure by state drug control authorities. [1]
- There is no separate national schedule in India that names 'peptides' as a class the way the U.S. FDA or other regulators do; each peptide compound's legal status in India instead depends on whether it individually has CDSCO marketing approval as a drug. [1]
Peptide-by-peptide status in India
| BPC-157 | BPC-157 has no CDSCO-approved drug status in India, meaning it cannot be legally manufactured or sold as a medicine, supplement, or injectable product for human use under the Drugs and Cosmetics Act. [1] |
|---|
| TB-500 | TB-500, like BPC-157, is an unapproved compound in India with no CDSCO marketing authorization, so its sale or manufacture for human use is not legally sanctioned. [1] |
|---|
| Semaglutide / Tirzepatide (GLP-1 peptides) | Semaglutide and tirzepatide are approved prescription medicines in India for diabetes and weight management, meaning they can only be legally dispensed by a licensed pharmacy against a doctor's prescription rather than sold over the counter. |
|---|
| Human Growth Hormone (HGH/Somatropin) | Somatropin (human growth hormone) is an approved prescription drug in India for specific medical indications like growth hormone deficiency, so its lawful use requires a doctor's prescription, and non-medical or bodybuilding use sourced outside licensed pharmacy channels is not legally sanctioned. |
|---|
Last researched: 2026-09-10
Frequently asked questions
No -- BPC-157 has no CDSCO-approved drug status in India at all, so there is no legal prescription pathway to buy it as a medicine, and any product sold as BPC-157 for human use would be an unapproved drug regardless of whether a prescription is offered.
[1]
Personal import of a small quantity of a genuinely approved prescription drug for one's own treatment is generally tolerated in India when accompanied by a valid prescription, but this does not extend to unapproved research peptides such as BPC-157 or TB-500, which have no approved status to be prescribed against.
Licensed Indian doctors can prescribe CDSCO-approved GLP-1 medicines like semaglutide and tirzepatide, including through registered telemedicine consultations under India's Telemedicine Practice Guidelines, but the drug must still be dispensed by a licensed pharmacy against that prescription.
Selling an unapproved 'new drug' such as a research peptide in India is an offence under the Drugs and Cosmetics Act, 1940, and can lead to seizure of the product plus criminal penalties including fines and imprisonment for the seller.
[1]
Human growth hormone (somatropin) is a legal prescription-only medicine in India for approved medical conditions like growth hormone deficiency, but buying it without a prescription or for non-medical bodybuilding purposes falls outside the legal, licensed-pharmacy pathway.